Vasoplegia: A Review
References
- Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018 Feb 27;22(1):52. doi: 10.1186/s13054-018-1967-3
- Burgdorff AM, Bucher M, Schumann J. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms. J Int Med Res. 2018 Apr;46(4):1303-1310. doi: 10.1177/0300060517743836
- Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg. 2010
Summer ;22(2):140-4. doi: 10.1053/j.semtcvs.2010.09.007 - Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015 Jan;349(1):80-8. doi: 10.1097/MAJ.0000000000000341
- Shaefi S, Mittel A, Klick J, et al. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy. J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032
- Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino). 1998 Oct;39(5):619-23.
- Tecson KM, Lima B, Lee AY, et al. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2018 May 17;7(11):
e008377 . doi: 10.1161/JAHA.117.008377 - Cebula B, Musfeldt D. 1664: METHYLENE BLUE TO MANAGE MULTIFACTORIAL VASOPLEGIC SHOCK. Crit Care Med. 2016 Dec;44(12):491. doi: 10.1097/01.ccm.0000510337.34856.e9
- Gamcrlidze MM, Intskirveli NA, Vardosanidze KD, Chikhladze Kh E, Goliadze L, Ratiani LR. Vasoplegia in septic shock (review). Georgian Med News. 2015 Feb;(239):56-62
- Muhammad R, Dharmadjati BB, Mulia EPB, Rachmi DA. Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass. Eurasian J Med. 2022 Feb;54(1):92-99. doi: 10.5152/eurasianjmed.2022.20394
- McIntyre WF, Um KJ, Alhazzani W, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528
- Mehaffey JH, Johnston LE, Hawkins RB, et al. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival. Ann Thorac Surg. 2017 Jul;104(1):36-41. doi: 10.1016/j.athoracsur.2017.02.057
- Bak MA, Smith JA, Murfin B, Chen Y. High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery. Cureus. 2022 Aug 22;14(8):
e28267 . doi: 10.7759/cureus.28267 - Dayan V, Cal R, Giangrossi F. Risk factors for vasoplegia after cardiac surgery: a meta-analysis. Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):838-844. doi: 10.1093/icvts/ivy352
- Suga M, Kawakami D, Ueta H, et al. Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome. J Anesth. 2020 Apr;34(2):243-249. doi: 10.1007/s00540-019-02727-0
- Bastopcu M, Sargın M, Kuplay H, Erdoğan SB, Yapıcı N, Aka SA. Risk factors for vasoplegia after coronary artery bypass and valve surgery. J Card Surg. 2021 Aug;36(8):2729-2734. doi: 10.1111/jocs.15663
- Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, Fischer GW. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 2009 Oct 27;120(17):1664-71. doi: 10.1161/CIRCULATIONAHA.108.814533
- Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005 May;79(5):1615-9. doi: 10.1016/j.athoracsur.2004.10.038
- Byrne JG, Leacche M, Paul S, et al. Risk factors and outcomes for ‘vasoplegia syndrome’ following cardiac transplantation. Eur J Cardiothoracic Surg. 2004 Mar;25(3):327-32. doi: 10.1016/j.ejcts.2003.11.032
- Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun;327(6122):524-6. doi: 10.1038/327524a0
- Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006 Apr 4;113(13):1708-14. doi: 10.1161/CIRCULATIONAHA.105.602532
- Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation. 2008 Apr 15;117(15):1991-6. doi: 10.1161/CIRCULATIONAHA.107.744540
- Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109-42
- Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001 Aug 23;345(8):588-95. doi: 10.1056/NEJMra002709
- Denninger JW, Marletta MA. Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta. 1999 May 5;1411(2-3):334-50. doi: 10.1016/s0005-2728(99)00024-9
- Lange M, Enkhbaatar P, Nakano Y, Traber DL. Role of nitric oxide in shock: the large animal perspective. Front Biosci (Landmark Ed). 2009 Jan 1;14(5):1979-89. doi: 10.2741/3357
- Maire JC, Medilanski J, Straub RW. Release of adenosine, inosine and hypoxanthine from rabbit non-myelinated nerve fibres at rest and during activity. J Physiol. 1984 Dec;357:67-77. doi: 10.1113/jphysiol.1984.sp015489
- Kerbaul F, Collart F, Giorgi R, et al. Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response. Crit Care Med. 2006 Mar;34(3):640-5. doi: 10.1097/01.CCM.0000201005.34203.50
- Saadjan AY, Lévy S, Franceschi F, Zouher I, Paganelli F, Guieu RP. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation. 2002 Jul 30;106(5):569-74. doi: 10.1161/01.cir.0000023924.66889.4c
- Mosqueda-Garcia R, Tseng CJ, Appalsamy M, Robertson D. Modulatory effects of adenosine on baroreflex activation in the brainstem of normotensive rats. Eur J Pharmacol. 1989 Dec 12;174(1):119-22. doi: 10.1016/0014-2999(89)90882-0
- Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999 Nov;89(5):1143-55. doi: 10.1213/00000539-199911000-00012
- Parkington HC, Coleman HA, Tare M. Prostacyclin and endothelium-dependent hyperpolarization. Pharmacol Res. 2004 Jun;49(6):509-14. doi: 10.1016/j.phrs.2003.11.012
- Endo H, Akahoshi T, Kashiwazaki S. Additive effects of IL-1 and TNF on induction of prostacyclin synthesis in human vascular endothelial cells. Biochem Biophys Res Commun. 1988 Oct 31;156(2):1007-14. doi: 10.1016/s0006-291x(88)80944-6
- Stuart MJ, Setty Y, Walenga RW, Graeber JE, Ganley C. Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. Pediatrics. 1984 Oct;74(4):548-53. doi: 10.1542/peds.74.4.548
- Riedo FX, Munford RS, Campbell WB, Reisch JS, Chien KR, Gerard RD. Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol. 1990 May 1;144(9):3506-12. doi: 10.4049/jimmunol.144.9.3506
- Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411-5. doi: 10.1038/332411a0
- Lüscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000 Nov 7;102(19):2434-40. doi: 10.1161/01.cir.102.19.2434
- Hynynen MM, Khalil RA. The vascular endothelin system in hypertension--recent patents and discoveries. Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):95-108. doi: 10.2174/157489006775244263
- Khanna A, English SW, Wang, XS, et al.; ATHOS-3 Investigators. Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154
- Russell JA. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care. 2007 Aug;13(4):383-91. doi: 10.1097/MCC.0b013e328263885e
- Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018 Jul 6;22(1):174. doi: 10.1186/s13054-018-2102-1
- Datt V, Wadhhwa R, Sharma V, Virmani S, Minhas HS, Malik S. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management. J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805
- Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004 Feb;77(2):496-9. doi: 10.1016/S0003-4975(03)01510-8
- Ortoleva J, Shapeton A, Vanneman M, Dalia AA. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options. J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2766-2775. doi: 10.1053/j.jvca.2019.12.013
- Marik PE. Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid. Nutrients. 2018 Nov 14;10(11):1762. doi: 10.3390/nu10111762
- Wieruszewski PM, Nei SD, Maltais S, Schaff HV, Wittwer ED. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series. A A Pract. 2018 Aug 15;11(4):96-99. doi: 10.1213/XAA.0000000000000752
- Yanase F, Bitker L, Hessels L, et al. A Pilot, Double-Blind, Randomized, Controlled Trial of High-Dose Intravenous Vitamin C for Vasoplegia After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2020 Feb;34(2):409-416. doi: 10.1053/j.jvca.2019.08.034
- Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017 Jun;151(6):1229-1238. doi: 10.1016/j.chest.2016.11.036
- Sevransky JE, Rothman RE, Hager DN, et al.; VICTAS Investigators. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial. JAMA. 2021 Feb 23;325(8):742-750. doi: 10.1001/jama.2020.24505
DOI: https://doi.org/10.14797/mdcvj.1245 | Journal eISSN: 1947-6108
Language: English
Page range: 38 - 47
Submitted on: Apr 17, 2023
Accepted on: May 3, 2023
Published on: Aug 1, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2023 Iqbal Ratnani, Rohan Kumar Ochani, Asim Shaikh, Hafsa Nazir Jatoi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.